Band 3, the anion exchanger of human erythrocytes, contains up to 14 transmembrane (TM) segments and has a single endogenous site of N-glycosylation at Asn 642 in extracellular (EC) loop 4. The requirements for Nglycosylation of EC loops and the topology of this polytopic membrane protein were determined by scanning N-glycosylation mutagenesis and cell-free translation in a reticulocyte lysate supplemented with microsomal membranes. The endogenous and novel acceptor sites located near the middle of the 35 residue EC loop 4 were efficiently N-glycosylated; however, no N-glycosylation occurred at sites located within sharply defined regions close to the adjacent TM segments. Acceptor sites located in the center of EC loop 3, which contains 25 residues, were poorly N-glycosylated. Expansion of this loop with a 4-residue insert containing an acceptor site increased N-glycosylation. Acceptor sites located in short (<10 residues) loops (putative EC loops 1, 2, 6, and 7) were not N-glycosylated; however, insertion of EC loop 4 into EC loops 1, 2, or 7, but not 6, resulted in efficient N-glycosylation. Acceptor sites in putative intracellular (IC) loop 5 exhibited a similar pattern of N-glycosylation as EC loop 4, indicating a lumenal disposition during biosynthesis. To be efficiently N-glycosylated, EC loops in polytopic membrane proteins must be larger than 25 residues in size, with acceptor sites located greater than 12 residues away from the preceding TM segment and greater than 14 residues away from the following TM segment. Application of this requirement allowed a significant refinement of the topology of Band 3 including a more accurate mapping of the ends of TM segments. The strict distance dependence for Nglycosylation of loops suggests that TM segments in polytopic membrane proteins are held quite precisely within the translocation machinery during the N-glycosylation process.
Band 3 (AE1) is the anion exchange (AE) 1 protein of the erythrocyte membrane where it catalyzes the electro-neutral exchange of Cl Ϫ and HCO 3 Ϫ (1-6). Human Band 3 is a 911-amino acid polypeptide that consists of two domains, an aminoterminal domain located in the cytosol that is involved in cytoskeletal interactions and a carboxyl-terminal membrane domain responsible for anion exchange. Current models (see Fig. 1 ) indicate that the membrane domain may contain up to 14 TM segments, but the disposition of many of the hydrophilic loops connecting putative TM segments with respect to the membrane has not been established (4, 5, 7, 8) .
Human Band 3 is N-glycosylated at Asn 642 within EC loop 4 (9, 10). The mouse, rat, and chicken proteins are also N-glycosylated on the same loop (4) . Interestingly, trout erythrocyte Band 3 is N-glycosylated on an expanded EC loop 3 (Z-loop) and does not contain an acceptor site in EC loop 4 (11) . AE2 and AE3, like trout Band 3, contain N-glycosylation sites in an expanded EC loop 3 but none in EC loop 4 (4) . The localization of N-glycosylated sites to single loops is a common feature of native polytopic membrane proteins (12) , although N-glycosylation of multiple loops is possible (13) .
The placement of novel N-glycosylation acceptor sites (AsnXaa-Ser/Thr) into putative extracellular or intracellular domains of polytopic membrane proteins has proven very useful in defining the folding pattern of the polypeptide in the membrane (14 -20) . Successful N-glycosylation requires that the acceptor site is exposed to the lumen of the endoplasmic reticulum during biosynthesis and is adequately spaced from the membrane surface (15, 20 -23) . In this paper, we have used this biosynthetic approach to refine the topology of Band 3 and to determine the requirements for N-glycosylation of loops in polytopic membrane proteins.
EXPERIMENTAL PROCEDURES
Materials-The following is a list of products and (in parentheses) their suppliers: MEGAscript TM in vitro transcription kit, DNase I, and the cap analog m7GpppGp (Ambion); rabbit reticulocyte translation system, canine pancreatic microsomes, and RNasin (Promega) 642 was mutated to Asp in the TM1/14 construct as described (24) . A series of unique N-glycosylation acceptor sites (Table I) were created in the TM1/14 N642D construct using oligonucleotide-directed mutagenesis and the double-stranded mutagenesis system from CLONTECH.
Expansion of EC Loop 3-A "megaprimer" PCR method (25, 26) was used to expand the size and to insert a novel N-glycosylation acceptor site into EC loop 3 in the TM1/14 N642D construct. The resulting mutant had the additional sequence Val-Asn-Ser-Ser inserted between Tyr 555 and Asn
556
. The flanking and mutagenic primers were: 5Ј-GCAGGGCATTCTCTTCGC-3Ј (forward primer), 5Ј-GTGGTGATCT-GAGACTCCAGG-3Ј (reverse primer), 5Ј-ACTGCTGTTAACGTAGT-TATAAGTCTTCTGTAGTG-3Ј (reverse mutagenic primer), and 5Ј-CTACGTTAACAGCAGTAACGTGTTGATGGTGCCCAAAC-3Ј (forward mutagenic primer). The bold lettering indicates the insertion that codes for the sequence Val-Asn-Ser-Ser. The underline indicates the position of a novel HpaI site that was used to screen for mutants.
Insertion of EC Loop 4 into EC Loops 1, 2, 6, and 7-Short EC loops were expanded by insertion of a 35-amino acid sequence derived from EC loop 4, containing the endogenous N-glycosylation acceptor site, into the TM1/14 N642D construct. Two oligonucleotide primers were used to synthesize a DNA segment corresponding to EC loop 4 with terminal XbaI sites by PCR (35 cycles at 94°C, 1 min; 53°C, 2 min; 72°C, 3 min). Primer 1 was a sense oligonucleotide, 5Ј-GCTTCTAGATACCTACAC-CCAGAAACTCTC-3Ј and primer 2 was antisense oligonucleotide 5Ј-GAGTCTAGAAACTCGGAACGCAAGCCCAGT-3Ј. The underline indicates the XbaI cleavage sites. A unique XbaI cleavage site is located in Band 3 cDNA in a position corresponding to EC loop 2. The PCR product was ligated directly into this XbaI site in TM1/14 N642D construct. The endogenous XbaI site was mutated by a silent mutation CTA-(Leu 484 )3 CTG in TM1/14 N642D construct. Single novel XbaI restriction sites were then introduced at positions corresponding to EC loops 1, 6, and 7 and IC loops 3, 5, and 6. The same PCR product as described above was inserted into the novel XbaI sites. The resulting amino acid sequences at the insertion sites of the mutants are EC loop 1, . . . . The amino acids in bold represent the inserted sequence corresponding to EC loop 4, and the underlined residues indicate amino acids that were altered or duplicated due to the creation of an XbaI restriction site. All mutations and insertions were confirmed by dideoxynucleotide chain termination DNA sequencing (27) .
In Vitro Transcription and Translation-Plasmid DNA was linearized downstream of the stop codon with HindIII or with SacI; in the latter case, the ends were blunted with Klenow DNA polymerase. DNA (1 g) was transcribed with T7 RNA polymerase in the presence of m 7 GpppGp for 4 h at 37°C using the Ambion in vitro transcription kit according to the manufacturer instructions. The DNA template was removed by digestion with 2 units of DNase I for 15 min at 37°C. The RNA was extracted with 1:1 phenol:chloroform, precipitated with 1/10 volume of 5 M ammonium acetate and 1 volume isopropyl alcohol, and then resuspended in diethylpyrocarbonate-treated water containing 2 units/l RNasin.
Translation in a rabbit reticulocyte lysate was performed according to the suppliers. One-tenth (0.5-2 g) of the RNA transcribed in vitro was added to 50 l of translation mixture, and translation was allowed to continue for 2 h at 30°C. The detergent C 12 E 8 at 0.1% (w/v) was included in the translation mixture lacking microsomes to reduce aggregation of the translated protein. Translation was also carried out in the presence of microsomal membranes (7 units/50 l, one unit of microsomes is the amount of membranes required to cleave the signal sequence of preprolactin by 50%). [ 35 S]Methionine at 1 Ci/l was included in all translation mixtures.
Alternatively, a coupled transcription/translation system supplied by MBI Fermentas was used. The transcription reaction was carried out with 0.3 g of DNA using T7 RNA polymerase in a total volume of 3 l. The sample was divided equally into three tubes, and the translation mix was added. Translation was carried out in the presence of 1) 0.1% 100 l of ice-cold 0.1 M Na 2 CO 3 , pH 11.5, followed by recovery of the stripped microsomes by centrifugation (16,000 ϫ g for 15 min) (24) . The translation products were examined by SDS gel electrophoresis (28) followed by autoradiography. The efficiency of N-glycosylation was determined by scanning autoradiographs of SDS gels of the cell-free translation products synthesized in the presence of microsomes using a Hoefer densitometer and MacIntegrator. The percentage of N-glycosylation was calculated from the integrated areas under the two peaks corresponding to the N-glycosylated and non-glycosylated full-length products. N-Glycosylation of the mutants was always compared with the wild-type TM1/14 construct synthesized in a parallel translation reaction.
RESULTS

Rationale-
The requirements for N-glycosylation of EC loops and the topology of Band 3 were determined by scanning Nglycosylation mutagenesis. The endogenous site of N-glycosylation at Asn 642 in EC loop 4 was mutated (N642D) to provide a non-glycosylated protein into which novel N-glycosylation acceptor sites (Asn-Xaa-Ser/Thr) could be introduced (Fig. 1) . The loops connecting TM segments are poorly conserved (6), and therefore, single site mutations within them are not expected to have a profound effect on protein topology. A cell-free system consisting of a reticulocyte lysate supplemented with microsomal membranes was used to assay the N-glycosylation status of the mutants. N-glycosylation at a single site will produce a uniform increase of about 2,500 in the molecular weight of the protein corresponding to the cotranslational attachment of the high mannose oligosaccharide, which only occurs in the lumen of the microsomes. To confirm that the shift in mobility was due to N-glycosylation, one translation reaction in each set of translation mixes included a competitive inhibitor of N-glycosylation, the acceptor peptide Ac-Asn-TyrThr-NH 2 . A truncated construct (TM1/14) (24) corresponding to the membrane domain of Band 3 ( Fig. 1 ) was used in these experiments to improve the yield of full-length translation product and to better visualize the difference in molecular weight due to N-glycosylation.
EC Loops 3 and 4 Mutations-The endogenous site at Asn 642 in EC loop 4 can be N-glycosylated by microsomal membranes in the reticulocyte translation system (Fig. 2, lanes 1 and 2) .
The non-glycosylated protein has a molecular mass of 48 kDa while the glycosylated protein is 3 kDa larger, consistent with the attachment of a single oligosaccharide chain. The average efficiency of N-glycosylation in the translation reaction was 65% (Table I) . Increasing the amount of microsomes in the translation reaction did not result in a significant increase in the level of N-glycosylation. It has been reported (29, 30 ) that acceptor sites containing Thr can be more efficiently N-glycosylated than those containing Ser. To test this with Band 3, the endogenous site was mutated from Asn 642 -Ser-Ser to Asn 642 -Ser-Thr; however, no increase in the level of N-glycosylation was observed in the cell-free system (Table I) . Both the Nglycosylated and non-glycosylated products were resistant to alkaline extraction showing that they were integrated into the lipid bilayer. The series of lower molecular mass bands around 35-40 kDa are due to internal initiation of translation at methionine residues located within TM 6 (24) .
EC loop 3 contains 25 residues and is sensitive to cleavage by extracellular chymotrypsin in intact red cells (31) . A construct containing the mutated endogenous acceptor site and a novel site (Asn 556 ) in the middle of EC loop 3 can be glycosylated as expected but only poorly ( Fig. 2 and Table I ). Other mutants containing acceptor sites one or two residues proximal (Asn 554, or Asn 555 ) were also N-glycosylated but again at low efficiency ( Fig. 2 and Table I ). This low efficiency may be due to the suboptimal size of EC loop 3 (12, 13) , which may place the acceptor sites too close to the end of a TM segment to be properly N-glycosylated (23) . To test this hypothesis, EC loop 3 was increased in size by insertional mutagenesis. This mutant contained the additional four residue sequence Val-Asn-SerSer between Tyr 555 and Asn 556 . The acceptor site within this insert was readily N-glycosylated (Fig. 2) . Thus, this loop must be larger than 25 residues in size to be efficiently N-glycosylated, which places the acceptor sites 12 residues or more from the adjacent TM segments.
Scanning N-glycosylation mutagenesis was performed on the endogenously N-glycosylated EC loop 4 to determine the spacing required for N-glycosylation of acceptor sites in loops. Acceptor sites located near the middle of this loop were N-glyco- sylated with an efficiency equal to the endogenous site (Table I and Fig. 3 ). One exception occurred with the sequon N647WS, which was poorly N-glycosylated relative to N647SS (Table I) . This confirms the observation that sequons containing tryptophans are poor acceptor sites (32) . Otherwise, the amino acid sequence context of acceptor sites in EC loop 4 had little effect on N-glycosylation in this cell-free assay. However, no N-glycosylation occurred at sites positioned close to either of the neighboring TM segments (Fig. 3 ). There was a sharp cut-off for N-glycosylation, which suggests that acceptor sites in loops must be positioned a minimum distance away from the lumenal ends of adjacent TM segments to reach the active site of the oligosaccharyl transferase. This requirement explains the poor N-glycosylation observed for the point mutations in EC loop 3.
EC Loop 4 Insertions-The results of cell-free translation of mutants containing acceptor sites in other putative EC loops are shown in Fig. 4 . No change in the mobility of the translation products occurred in the presence of microsomes for any of the mutants containing acceptor sites in EC loops 1, 2, 6, or 7. According to the folding model presented in Fig. 1 , these loops are very short (5-10 residues), which may account for their inability to be N-glycosylated.
To determine the orientation of short loops with respect to the membrane, insertion of EC loop 4 into engineered XbaI sites was performed. A similar strategy was employed in investigations of the topology of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (15), the glucose transporter GLUT1 (18) , and the sodium-dependent glucose transporter (20) . The translation products containing the EC loop 4 insert are about 3 kDa larger than the corresponding TM1-14 proteins confirming that the expressed proteins contain the additional amino acid sequence. EC loop 4 inserted into EC loop 1 was N-glycosylated (Fig. 4) , in contrast to the point mutation in EC loop 1. This confirms that acceptor sites in short loops facing the lumen of the endoplasmic reticulum cannot reach the active site of the oligosaccharyl transferase. The efficiency of N-glycosylation of this loop was close to the levels found for the wild type protein a Loops are designated EC or IC according to the model shown in Fig.  1 . Approximate loop sizes are estimated from the number of residues between the ends of consecutive hydrophobic TM segments as shown in Fig. 1. b Quantitation of N-glycosylation was assayed by cell-free translation in the presence of microsomes. The percent N-glycosylation was calculated (Ϯ standard deviations) from scans of the autoradiographs. The number of determinations are in brackets.
c Four amino acid insertion into EC loop 3 between Y555 and N556. d Insertion of EC loop 4 (endogenous N-glycosylation site) into EC loops 1, 2, 6, 7, or IC loops 3, 5, and 6 in the TM1/14 N642D construct. (Table I) for separate translation experiments as a function of position of the acceptor site. (Table I ). This result shows that the inserted loop is accessible to the lumen of the endoplasmic reticulum and that this region of Band 3 is extracellular. Insertion of EC loop 4 into the endogenous XbaI site in EC loop 2 or EC loop 7 also resulted in optimal N-glycosylation (Fig. 4 and Table I ). In contrast, the insert in EC loop 6 was N-glycosylated at a lower level (Fig. 4 and Table I ). The low level of N-glycosylation observed for the insert in EC loop 6 suggests that only partial translocation of the loop into the lumen of the microsomes occurred in the cell-free system. A series of control EC loop 4 insertions into IC loops 3, 5, and 6 were also made. Insertions in IC loops 3 or 6 resulted in barely detectable N-glycosylation (Table I ). The low level of N-glycosylation of these cytosolic loops suggests that some aberrant translocation had likely occurred during cellfree translation. Insertion into IC loop 5, however, resulted in a high level of N-glycosylation (Table I) , inconsistent with a cytosolic disposition for this loop (see below). The insertion mutants suggest that EC loops 1, 2, and 7 and IC loop 6 in Band 3 are lumenal during biosynthesis while the disposition of putative EC loop 6 is ambiguous.
IC Loop Mutations-Figs. 5 and 6 show the results of a set of experiments with site-directed mutants containing acceptor sites in putative IC loops 5 and 6 and the carboxyl-terminal tail of Band 3. IC loop 5 contains a site at Lys 743 that can be partially cleaved by trypsin contained within resealed ghosts (33) . A point mutation (K743N) was made at this particular lysine to create a novel N-glycosylation acceptor site. Fig. 5 shows that this site, contrary to the 14 TM model, was Nglycosylated, suggesting that this hydrophilic loop is lumenal. This agrees with the results of the EC loop 4 insertion into IC loop 5. To confirm this finding, scanning N-glycosylation mutagenesis was performed on this loop. Acceptor sites located centrally between residues 735 and 748 were N-glycosylated; however, sites located close to the ends of the neighboring TM segments were not ( Fig. 5 and Table I ). This pattern of Nglycosylation was very similar to that found for the EC loop 4. These results show that this part of Band 3 is exposed to the lumen of the microsomes during biosynthesis and that acceptor sites in this loop must also be adequately spaced from the adjacent TM segments to be efficiently N-glycosylated. It is unlikely that all the individual point mutations in IC loop 5 resulted in a change in the orientation of this loop. Acceptor sites in IC loop 6 (Asn 821,828 ) or in the carboxyl-terminal tail (Asn 880 ) were not N-glycosylated, consistent with their intracellular disposition (Fig. 6 ). The lack of N-glycosylation of IC 6 and the carboxyl-terminal tail also confirms the specificity of the N-glycosylation assay. (Table I) loops in Band 3 were not N-glycosylated. However, insertion of EC loop 4 into these loops permitted efficient N-glycosylation. These findings are in agreement with observations made with other multispan membrane proteins in which short exofacial loops were also found to be poorly N-glycosylated (15, 18, 20 -22) .
A survey of polytopic membrane proteins revealed that EC loops containing N-linked oligosaccharides have a minimum size of about 30 residues, with the N-glycosylation site at least 10 residues away from a transmembrane segment (12) . The distance between the oligosaccharyl transferase active site and the endoplasmic reticulum membrane has been determined using the Escherichia coli leader peptidase as a model membrane protein (23) . This protein contains two TM segments with both the amino and carboxyl termini located in the periplasmic space. It was found that acceptor sites must be spaced greater than 12 residues COOH terminal from the second TM segment or greater than 14 residues NH 2 terminal from the first TM segment to reach the active site of the lumenal oligosaccharyl transferase. The experiments described in this paper define similar limits for N-glycosylation of loops in the polytopic membrane protein Band 3. The distance requirements found for the leader peptidase can be applied to loops in polytopic membrane proteins. Thus, the acceptor site asparagine in loops must be spaced greater than 12 residues from the proximal and 14 residues from the distal TM segment to be efficiently N-glycosylated. For simplicity, this will be referred to as the "12 ϩ 14 rule".
Mapping the Ends of TM Segments-The lumenal ends of TM segments can be mapped within a residue or two using the 12 ϩ 14 rule. Acceptor sites at Asn 554 , Tyr
555
, or Asn 556 in EC loop 3 are all poorly N-glycosylated, suggesting that they are closer than 12 or 14 residues from the ends of TM segments 5 and 6, respectively. The acceptor site in the four amino acid insertion (VNSS) between residues 555 and 556 in EC loop 3 can be N-glycosylated. This information maps the end of TM segment 5 to Phe 544 and the beginning of TM segment 6 to Pro 568 , in agreement with the hydropathy analysis (Fig. 7) .
TM segment 7 contains a well defined 21-residue hydrophobic sequence that extends from Val 604 to Ile 624 (Fig. 3) . This segment is bordered by hydrophilic sequences including a pair of arginines on the cytosolic side of the membrane and a poorlyconserved Gln 625 on the lumenal side (6). The closest acceptor site to TM segment 7 in EC loop 4 that can be N-glycosylated is located at Gly 637 . The 12 ϩ 14 rule would place the end of TM7 at Ile 624 , 13 residues away from Gly 637 , in perfect agreement with the hydropathy profile prediction. Maximal N-glycosylation occurred at Lys 639 , two additional residues away from Gly 637 . Hydropathy profiles predict that a 21-residue segment corresponding to TM 8 begins at Pro 660 and ends at Leu 680 . An acceptor site at Trp 648 can be N-glycosylated, with maximal N-glycosylation one residue proximal at Gly 647 . The 12 ϩ 14 rule defines the beginning of TM 8 at Met 663 , spaced 15 residues away from Trp 648 . The N-glycosylation pattern for IC loop 5 is similar to EC loop 4, suggesting a lumenal disposition in the endoplasmic reticulum. The acceptor site at Ala 735 is N-glycosylated, placing it greater than 12 residues away from the end of the preceding TM segment. This positions the end of TM segment 9 at Pro 722 . Similarly, the N-glycosylated acceptor site at Ala 749 must be greater than 14 residues away from the beginning of TM 10. The first residue of TM 10 can be localized to Leu 764 , which defines the clear beginning of a very hydrophobic sequence (Fig. 7) . This places the EC loop 4 insertion into EC loop 7 at Leu 785 in the middle of the TM 10 ( Fig. 7) , which may account for its partial translocation.
Biosynthetic Considerations-The finding that acceptor sites in loops must be located a minimum distance away from adjacent TM segments to be N-glycosylated shows that TM segments are held quite precisely within the endoplasmic reticulum membrane during the N-glycosylation process (23) . This precision is likely due to the interaction of TM segments with elements of the translocation machinery including the Sec61p complex and TRAM (34 -37) . These segments assume a helical conformation before entering the hydrophobic phase of the lipid bilayer (38, 39) . The positioning of these helical TM segments 2) ; N851 ( lanes 3 and 4) ; N828 ( lanes 5 and 6) , and the C-terminal mutant, N880 (lanes 7 and 8) . Translation conditions were as in Fig. 2. within the translocon may be a prerequisite to their lateral movement into the membrane.
Polytopic membrane proteins usually contain a single Nglycosylated loop, and this loop is usually the largest EC loop in the protein (12) . The results obtained in this study show that acceptor sites located in small loops or those in large loops located too close to a TM segment cannot reach the active site of the lumenal oligosaccharyl transferase. This would account for the lack of N-linked carbohydrate on acceptor sites found in short loops in some polytopic membrane proteins (12) . The ability to N-glycosylate loops placed in various positions within the sequence of Band 3 and other polytopic membrane proteins (13, 15, 18, 20) shows that all lumenal loops of sufficient size are scanned by the active site of the oligosaccharyl transferase. This efficiency is due to intimate association of this lumenal enzyme with the translocation machinery in the endoplasmic reticulum (40 -42) .
Band 3 (45) . A recent study of the membrane insertion of truncated Band 3 molecules has shown that EC loop 2 is lumenal (46) , in agreement with the results obtained in this paper. The conclusion that this loop is extracellular is not, however, supported by the examination of the orientation of Tyr 486 (47) . In that study, it was observed that Tyr 486 could be radioiodinated by lactoperoxidase in inside-out vesicle but not in intact cells. Unfortunately, a labeled peptide corresponding to the predicted sequence Y 486 IVGR could not be unambiguously identified, and the yield of purified peptide was low, such that the total dpm in the final peptide fraction were only slightly above background. An expanded EC loop 3 can be N-glycosylated, and EC loop 4 contains the endogenous Nglycosylation site, consistent with the model in Fig. 1 .
Contrary to the predictions of the model in Fig. 1 , acceptor sites or the EC loop 4 insertion in the middle of IC loop 5 were N-glycosylated. These results suggest that during biosynthesis this loop is exposed to the lumen of the endoplasmic reticulum. This conclusion is consistent with the analysis of hydropathy profiles (6) that predicts that there is only one TM segment between residues Lys 698 to Arg 730 (Fig. 7) . A previous study (33) , however, showed that trypsin within resealed ghosts can partially cleave Band 3 at Lys 743 , producing a carboxyl terminal 20-kDa fragment at low yield. No such fragment could be produced by extensive treatment of intact cells with trypsin, suggesting that this site is exposed to the cytosolic side of the membrane. Soluble peptides derived from this loop can be produced by trypsin digestion of ghost membranes but only if Band 3 is first alkaline-denatured (45, 48 ). It appears that Lys 743 is partially accessible from the cytosolic side of the membrane in the mature, folded protein but is lumenal during Fig. 1 are now a single TM segment 9. The original IC loop 5 is on the lumenal side of the membrane during biosynthesis but is shown to loop into the protein to place K743 near the cytosolic side of the membrane. The original TM segments 11 and 12 in Fig. 1 are shown as a single TM segment but may span the membrane three times. The sequence between C843, which is palmitoylated, and the final EC loop is depicted as an extended structure. The final TM segment places the carboxyl terminus in the cytosol. Nt, amino terminus; Ct, carboxyl terminus; T, trypsin cleavage site. C, chymotrypsin cleavage site; Pa, papain cleavage site. Note that most of the trypsin and papain cleavage sites are only accessible after denaturation of the protein (45) . biosynthesis (Fig. 7) . The lumenal exposure of this loop may be a feature of an intermediate in the folding pathway of Band 3. It was noted that the maximal level of N-glycosylation of sites within this loop was uniformly lower than that observed for the endogenous site (Table I) . This hydrophilic loop is about 40 residues in length, which is large enough to be efficiently Nglycosylated. It is known that competition occurs between the processes of N-glycosylation and protein folding in the lumen of the ER (49) . If this loop folds rapidly during biosynthesis, this may be responsible for limiting the extent of N-glycosylation. During the cell-free translation, this loop, in a fraction of the molecules, became trapped in the lumen by N-glycosylation at the novel acceptor site. Normally this loop folds into the protein to expose Lys 743 to the cytosolic side of the membrane (Fig. 7) . It is also possible that this part of Band 3 exhibits alternative topologies as has been reported for P-glycoprotein (50, 51) and has a dynamic aspect.
N-glycosylation acceptor sites located in the IC loop 6 were not N-glycosylated, consistent with their cytosolic location. This is in agreement with previous studies using monoclonal antibodies that localized the epitope encompassing Phe 813 to Tyr 824 on the cytosolic side of the membrane (52) . The loop containing Lys 743 and the cytosolic IC 6 are separated by a long hydrophobic sequence with a short hydrophilic and poorly conserved region (Glu 777 -Arg 782 ), corresponding to putative EC loop 6 near the middle (Fig. 1) . Insertion of EC loop 4 at the position of EC loop 6 resulted in poor N-glycosylation, inconsistent with a lumenal disposition for this region. We suspect that partial translocation of the EC loop 4 insertion occurred in the cell-free system due to disruption of the hydrophobic domain and its stop-transfer function. It is known that the aminoterminal halves of TM segments are not sufficient to act as a stop-transfer element in lactose permease-alkaline phosphatase fusions (53) . Partial translocation and N-glycosylation of a large insert has also been observed with the glucose transporter (18) .
Insertion of EC loop 4 into EC loop 7 resulted in efficient N-glycosylation of the mutant, placing EC loop 7 on the extracytosolic side of the membrane (Fig. 7 ). This agrees with the finding that the mutation P864L is associated with the Diego blood group antigen (54) . In addition, Lys 851 , also located within EC loop 7, can be labeled with H 2 DIDS from the cell exterior, and a small peptide (Val 849 -Ala 855 ) can be released from the membrane by extensive proteolysis (45) . An N-glycosylation acceptor site within the carboxyl-terminal tail of Band 3 was not N-glycosylated. These results agree with previous studies (52, 55, 56) using antibodies to map the carboxyl terminus of Band 3 to the cytosolic side of the membrane. Cys 843 is palmitoylated (57) , which positions this residue on the cytosolic side of the membrane with the fatty acid extending into the inner leaflet of the lipid bilayer. The number of amino acids (ϳ10) between the palmitoylated Cys 843 and the last hydrophilic EC loop (K 851 STP) is not sufficient to cross a 30 Å bilayer as an ␣-helix. This short sequence is not likely to be exposed to the lipid bilayer but would be protected within a bundle of outer helices formed by other TM segments (58) .
